Yes the government will start to push generic competition yet again and it has already cut down considerably the length of time it takes to approve generic drugs. A few years back Elite had a professional company evaluate what Elite was worth prior to putting a poison pill in place. Back then the company was worth 40 cents on the existing generic pipeline alone minus it's ADT pipeline. Mind you the share count has doubled since then and 2 of Elite's generic products have been stalled due to Epic and/or the FDA.
It is clear Nasrat was bred in the generic BP world and he has brought that skill set to Elite. The hiring of Doug Plassche shows this as but one example. There are no generic ADT opioids on the market currently and Elite will file a generic ADT oxycontin later this year.
I like what I'm seeing regarding Nasrat filing way more lucrative generic Andas than Elite owns currently. Generic Percocet and Narco are other examples.
Elite is turning into a nice little generic pharma company with the possibility of several ADT opioids to boot.
If they can approve the generic Percocet, Narco, Oxycontin and get SequestOx approved this is an easy 10 plus bagger IMO..........then you have another 4 generic SunGen products in a $3 billion dollar market.
There is a lot going on under the hood that the company has not received its fair share of compensation for yet.
News 
Market Data 
Discover 
